HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084

By sjmartinez • October 29, 2024

Fogel JM, Persaud D, Piwowar-Manning E, Richardson P, Szewczyk J, Marzinke MA, Wang Z, Guo X, McCauley M, Farrior J, Tran HV, Ungsedhapand C, Mathew CA, Mpendo J, Rinehart AR, Rooney JF, Cohen MS, Hanscom B, Grinsztejn B, Hosseinipour MC, Delany-Moretlwe S, Landovitz RJ, Eshleman SH; HPTN 083 and HPTN 084 Study Teams. HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084. AIDS Res Hum Retroviruses. 2024 Oct 28. doi: 10.1089/aid.2024.0049. Epub ahead of print. PMID: 39466048.

Tags: Cabotegravir, DNA, HIV, HIV Prevention Trials Network, Infectious Diseases, Pre-exposure prophylaxis, prevention, Publications

Related Posts

Uptake of the COVID-19 vaccine and its association with vaccine information and misinformation in Malawi

Songo J, Whitehead HS, Phiri K, Kalande P, Lungu E, Phiri S, van Oosterhout J, Moses A, Hoffman RM, Moucheraud C. Uptake of the COVID-19[...]

Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study

Maertens JA, Thompson GR 3rd, Spec A, Donovan FM, Hammond SP, Bruns AHW, Rahav G, Shoham S, Johnson R, Rijnders B, Schaenman J, Hoenigl M,[...]

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment

Munroe ES, Grandits GA, Hyzy RC, Prescott HC, Barrett TW, Dewar RL, Engen N, Goodman AL, Hatlen TJ, Highbarger H, Holland TL, Hughes G, Jensen[...]